Announcing a Drop in the Price of the 4Kscore™ Test

We often hear from patients and physicians alike interested in learning more about the 4Kscore test as well as the associated cost. We have always worked to offer the 4Kscore tests at a reasonable price. With our Patient Health Advocacy Program, we are committed to increasing access to the 4Kscore for patients who do not have health insurance. Through these efforts, we have been successful in making comprehensive testing available to an expanding network of patients.

The New Price of the 4Kscore Test

We are very excited to announce that the 4Kscore test is now more affordable. The price has been reduced from $1900 to $595, making testing more accessible to men at an increased risk of having aggressive prostate cancer. If you would like to discuss your specific situation, and our self-pay and payment plan options, please call our specialized billing hotline at 855-4KBILLING (855-452-4554) between the hours of 9am and 9pm EST, Monday-Friday.

The Cost of Unnecessary Biopsies

As we recently discussed in a post on the topic, the cost associated with unnecessary biopsies preformed in the United States annually is staggering. Not only is the 4Kscore aiding in the biopsy decision making process, it can help to reduce the number of unnecessary biopsies performed on an annual basis.

In helping patients, along with their doctors, make informed decisions about prostate biopsies, the 4Kscore is dramatically reducing the pain and cost associated with unnecessary procedures.1 In reducing the cost of the 4Kscore, we aim to make an even greater impact in the fight against prostate cancer.

Learn More About the 4Kscore Test

Whether you are a patient or a physician, we encourage you to contact us today. Learn more about the benefits of the 4Kscore. Find a laboratory in your area or begin offering the 4Kscore in your practice. Together we can make a difference!

 

  1. Voigt, J. D., MPH, MBA, Dong, Y., PhD, Linder, V., PhD, & Zappala, S., MD. (2017). Use of the 4Kscore Test to Predict the Risk of Aggressive Prostate Cancer Prior to Prostate Biopsy: Overall Cost Savings and Improved Quality of Care to the US Healthcare System. Reviews in Urology, 19(1), 1-10.

We Hope to See You at AUA2017!

The American Urological Association’s 2017 Annual Meeting is just around the corner. This annual event provides the ideal platform for thought leaders in the field to explore the latest advances in urologic medicine. Attendees from around the globe will gather in Boston, Massachusetts, May 12 – 16, for the 112th AUA Annual Meeting. Last year’s meeting attracted more than 16,000 attendees, from 111 countries, a testament to its significance in the international urologic medical community.

Connect with GenPath at Booth 904

At GenPath, we are gearing up for AUA2017 and we hope to see you there! Be sure to visit our booth to learn more about the larger impact of the 4Kscore. Connect with our team and get answers to your questions.

Join us throughout the week for talks and symposiums including:

Advancements in Prostate Cancer Diagnostics: Genetic Testing & 4Kscore

Attendees will learn about an exciting development from our genetics division, GeneDx; a new panel that tests for hereditary prostate cancer genes to help patients understand their genetic risk for the disease and clinicians make management decisions. We will also explore how the 4Kscore and genetic testing can fit into the urology practice.

  • Speakers:
    • Benjamin D. Solomon, MD, FACMG – Managing Director, GeneDx
    • Sanoj Punnen, MD, MAS – Assistant Professor of Urologic Oncology, University of Miami, Miller School of Medicine and Sylvester Comprehensive Cancer Center
    • Mitchell Steiner, MD, FACS – Moderator
  • Date: Sunday, May 14, 2017
  • Time: 10:00AM – 11:00AM
  • Location: ICU Theatre – Booth 1354

Pre-register today!

4Kscore: An Actionable Biomarker in an Era of Accountable Care

Attendees will learn more about 4Kscore and how their patients will benefit from the test.

  • Speaker: Dr. Steve Zappala
  • Dates/Times: Saturday 5/13 and Monday 5/15 at 10:30AM
  • Location: Booth 904

GeneDx: Supporting Urologists in the Evaluation of Hereditary Prostate Cancer through Genetic Testing

Attendees will discover how genetic testing can easily fit into a Urologist’s practice and inform medical management.

  • Speaker: Lance Grau (Genetic Counselor for GeneDx)
  • Dates/Times: Saturday 5/13, Sunday 5/14, and Monday 5/15 at 12:30PM
  • Location: Booth 904

The Role of 4Kscore and Multiparametric MRI for Diagnosing Aggressive Prostate Cancer

Attendees will learn how Urologists are combining the 4Kscore and MRI in the evaluation of men suspected of having aggressive prostate cancer.

  • Speaker: Dr. Jay Newmark
  • Dates/Times: Saturday 5/13, Sunday 5/14, and Monday 5/15 at 2:30PM
  • Location: Booth 904

Discover More About the 4Kscore at AUA2017

Not only will we be sponsoring a booth and hosting a number of talks, the 4Kscore will also be featured in AUA Curriculum by independent physicians. Do not miss your chance to learn more about the vital role the 4Kscore is playing in modern urologic medicine.

The 4Kscore Test Accurately Predicts Aggressive Prostate Cancer in Men of all Ages and Race

  • Date: Friday, May 12, 2017
  • Time: 9:30AM

A four-kallikrein panel in predicting high-grade prostate cancer on biopsy: an independent replication from the Finnish section of the European Randomized Study of Screening for Prostate Cancer

  • Date: Sunday, May 14, 2017
  • Time: 10:20AM

Combining 4Kscore and MRI for Prostate Biopsy Decision Making

  • Date: Sunday, May 14, 2017
  • Time: 10:40AM

Does 4K and/or Michigan Prostate Score Change Cancer Detection Rates in Multi-Parametric MRI discovered PIRADS 3 or Lower Lesions

  • Date: Tuesday, May 16, 2017
  • Time: 8:20AM

An Independent, Multi-Institutional, Prospective study in the Veterans Affairs Health System confirms the 4Kscore accurately predicts aggressive prostate cancer

  • Date: Tuesday, May 16, 2017
  • Time: 10:00AM

Ready to Learn More About the 4Kscore?

Will you be attending AUA2017? If so, we encourage you to visit our booth and to take in the symposiums and talks outlined above. If you will not be attending this year’s meeting, be sure to connect with us on Facebook, Twitter, Google+ and LinkedIn. Stay in-the-know about the exciting advancements in urological medicine that will be announced at this year’s meeting. Join in the conversation!

 

GenPath is a division of BioReference Laboratories, Inc.

Why the 4Kscore is Important to Physicians and Patients

Nearly 3 million men live with prostate cancer in the US, with more than 160,000 new cases diagnosed each year[1].  Prostate cancer remains the second leading cause of cancer death in men[2], which is why it’s important to find aggressive prostate cancers early when treatment can still be effective.  Unfortunately, current methods for screening and evaluating men for this disease have led to overuse of prostate biopsies, which can also lead to unnecessary complications.  This is why physicians are now using the 4Kscore, which is a simple blood test used after an abnormal screening test, to provide the risk of aggressive prostate cancer.

4Kscore Provides The Risk Of Aggressive Prostate Cancer

Screening with PSA and a digital rectal examination (DRE) is a routine part of many men’s regular examinations, and has led to a significant drop in prostate cancer deaths.  Screening with PSA is normally done in age appropriate men, and earlier in men with additional risk factors.  While PSA has been successful in finding many prostate cancers at a stage early enough to treat, it does a poor job of differentiating aggressive prostate cancers from indolent cancer, and can even be elevated in many benign conditions like Benign Prostatic Hyperplasia (BPH: a common condition for most men as they get older) [3].  As a result, there is significant controversy about continuing to use PSA as a routine screening test.

This is why a test like 4Kscore is so important to physicians and men concerned about their risk of aggressive prostate cancer.  4Kscore is a blood test performed after an abnormal PSA or DRE result.  It measures the values of 4 prostate specific biomarkers in the blood and combines them with clinical results, resulting in a score that accurately predicts an individual’s risk of aggressive cancer.  It can help avoid unnecessary prostate biopsies in low risk men, while higher risk men will continue to be appropriately evaluated with a biopsy.  4Kscore has been extensively evaluated in numerous published clinical studies, including a large US based prospective study at 26 centers around the country.  It has been shown to provide risk for high-grade cancer and also categorizes risk for developing distant metastasis.

Making An Informed Decision About Prostate Biopsies

With the 4Kscore, patients and physicians can make a more informed decision about the benefits and risks of getting a prostate biopsy.  Prostate biopsies can in some cases have complications like pain, bleeding, sepsis, and may lead to hospitalization, with its associated costs.  Currently, screening with PSA and DRE alone has resulted in the majority of biopsies having no or indolent cancer.  By using the 4Kscore in men with an abnormal screening result, many of these unnecessary biopsies can be avoided.  This leads to better clinical decision making, while also reducing costs to the patient and the healthcare system.

Is the 4Kscore Test Available at Your Practice?

At GenPath and BioReference, OPKO Health companies, we often hear from physicians and patients alike inquiring about the 4Kscore Test. If you are a physician interested in offering the 4Kscore Test in your practice, we encourage you to contact us today. Begin offering the 4Kscore Test to your patients and get listed in our physician locater tool. If you are a patient who would like to encourage your physician to begin offering the 4Kscore Test, we also encourage you to reach out to us. Together we can make the 4Kscore Test even more readily available.

If you are interested in learning more about prostate health through precision medicine, follow our blog and connect with us on Facebook, Twitter, Google+ and LinkedIn.

 

This Valentine’s Day, Show Your Loved Ones You Care About Your Health

Valentine’s Day is one of those holidays that comes with a certain amount of trepidation for most of us. The stress of selecting the right gift can take the fun out of the sentiment. However, we might just have the perfect gift idea for the special person in your life; peace of mind for your prostate health with the 4Kscore Test.

Show Them You Care About Your Health

It is not uncommon for men to forgo preventative healthcare services and to avoid medical treatment altogether. In fact, research from the Centers for Disease Control and Prevention (CDC) found that women are 33% more likely than their male counterparts to visit their doctor and 100% more likely to seek preventative services. 1 If your loved one has encouraged you to take a more proactive approach to health screenings, maybe it’s time to listen. This Valentine’s Day, why not show your loved ones just how much you care by getting a 4Kscore Test?

What is the 4Kscore Test?

The 4Kscore is a simple blood test that is performed after an abnormal screening test such as PSA, leveraging cutting edge advances in medical science to determine a patient’s risk for aggressive prostate cancer. The test measures four prostate-specific biomarkers in the blood, which are combined with clinical findings into an algorithm to provide a man’s risk of having aggressive prostate cancer on a scale from <1% to >95%. By getting a simple blood test, you and your special Valentine can rest assured that you are taking an active role in your prostate health.

Who Should get the 4Kscore Test?

The 4Kscore Test is intended for any man after an abnormal PSA or other prostate cancer testing, as a means to provide his risk of high-grade, aggressive prostate cancer before making a biopsy decision. If you have had an abnormal PSA, the 4Kscore can provide the answers you and your loved ones are seeking. Contact your physician, ask the right questions, and get tested at a 4Kscore test laboratory in your area.
Have questions about the 4Kscore test? We encourage you to peruse our website for answers to a wide variety of frequently asked questions, or email us directly at 4kscoreinquiry@bioreference.com. Would you like more tips to help you take an active role in your prostate health? Subscribe to our blog for insights and information throughout the year.

 

1) Centers for Disease Control and Prevention (CDC). Women more likely than men to visit the doctor, more likely to have annual exams. Available at https://www.cdc.gov/nchs/pressroom/01news/newstudy.htm. (Accessed on January 24, 2017).

4Kscore Test: A Clinically Proven Prostate Cancer Test

The 4Kscore accurately provides the risk of aggressive prostate cancer, reducing the number of unnecessary prostate biopsies performed annually. The accuracy of the 4Kscore algorithm to provide the risk of high grade prostate cancer is based on over a decade of research completed by scientists at Memorial Sloan Kettering Cancer Center and other leading international cancer research centers.

4Kscore Test: A Clinically Proven Prostate Cancer Test

The 4Kscore Test has undergone a wide variety of clinical studies in reputable research facilities, in the US and abroad. Some highlights:

  • The 4Kscore was validated in a prospective blinded clinical study conducted at 26 urology centers across the United States on more than 1,012 patients. The 4Kscore demonstrated a near perfect calibration to actual prostate biopsy results, with a significantly higher accuracy than PSA for high grade prostate cancer.1
  • In a landmark case-control study including 12,542 men, the 4Kscore’s ability to predict risk of developing distant metastasis in men with a suspicious PSA for their age was evaluated. Men who had a suspicious PSA and a 4Kscore of 7.5% or less had a very low risk (< 0.3%) of developing distant metastasis within 10 years.2
  • In a retrospective study, where the 4Kscore was provided to 611 patients seen by 35 academic and community urologists across the United States, a reduction in prostate biopsies of 64.6% was reported.  There was a 94% reduction in prostate biopsies in men with a low risk 4Kscore (< 7.5%).3

Additional studies include:

Accurately Identify Risk of Aggressive Prostate Cancer with the 4Kscore

Prostate cancer is the second most common cancer among men, and it is estimated that nearly three million men are living with the disease in the United States. Having the ability to accurately identify a man’s risk of having aggressive prostate cancer not only saves lives but dramatically decreases the number of unnecessary biopsies, which can be both painful and costly.  The 4Kscore Test measures 4 prostate-specific kallikreins in the blood: Total PSA, Free PSA, Intact PSA, and Human Kallikrein 2 (hK2), which are combined with important clinical findings to provide the risk of aggressive prostate cancer. With  extensive research and validation to back it up, the 4Kscore Test is revolutionizing the way doctors and patients approach prostate cancer diagnosis.

If you would like to learn more about the 4Kscore Test, we encourage you to contact us today or find a laboratory in your area.

 

  1. A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer. Eur Urol 2014; 68(3):464-470
  2. Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case–Control Study. Eur Urol 2015; 68 (2): 207-213
  3. The 4Kscore® Test Reduces Prostate Biopsy Rates in Community and Academic Urology Practices. Reviews in Urology 2015. 17(4): 231-240

 

What Happens If Your Physician Does Not Offer 4Kscore™ Test?

This time of year, health is a core focus for many of us. With a new year comes new beginnings and the opportunity to refocus our attention on the people and areas of our lives that matter most. If you aim to take a more proactive approach to your health in 2017, we congratulate you.

At BioReference Laboratories and GenPath Diagnostics [OPKO Health Companies], we work year-round to help men and their physicians determine their risk for aggressive prostate cancer. With nearly 3 million men living with prostate cancer in the United States, it is our goal to arm physicians with the information they need to help identify and treat men with aggressive prostate cancer. If you, or a loved one, have reason to believe you are at an elevated risk of having prostate cancer, be it from family history or an elevated PSA, the 4Kscore can help provide the answers you need.

What is the 4Kscore Test?

The 4Kscore is a simple blood that is performed after an abnormal screening test such as PSA, leveraging cutting edge advances in medical science to determine a patient’s risk for aggressive prostate cancer. The test measures 4 prostate-specific kallikreins in the blood: Total PSA, Free PSA, Intact PSA, and Human Kallikrein 2 (hK2), which are combined with clinical findings into an algorithm to provide a patient’s risk of aggressive prostate cancer. This test is more specific than PSA for aggressive prostate cancer, providing an accurate risk of having high grade cancer along with the long-term risk of developing metastasis. Using the 4Kscore will help your doctor make an informed decision about whether or not you need a prostate biopsy. The test can also help your physician find aggressive prostate cancer earlier, or help to avoid an unnecessary prostate biopsy if you are low risk.

What if Your Doctor Does Not Offer the 4Kscore Test?

If you are interested in undergoing a 4Kscore test, we encourage you to first speak to your physician Should you discover that they do not offer the 4Kscore test, encourage your doctor to sign up to offer the 4Kscore test or provide us with their information and we can have on of our dedicated account executives can follow-up to discuss their practice needs. Alternatively, you can use our online search function to find an offering physician in your area who currently offers the 4Kscore test. If our search directory does not return a viable option near you, contact our Customer Service team at 1- 1-833-4Kscore for additional assistance. It is our goal to educate patients and physicians about the benefits of the 4Kscore and to make it readily available from coast to coast.
If you are concerned about the cost of the 4Kscore test, we encourage you to read our recent post on the topic to learn about insurance coverage. Also learn about the self-pay and payment plan options we offer to patients who do not have health insurance or for those who choose not to submit a claim to their insurance company. Finally, download our patient brochure to learn what you need to know about the 4Kscore test or download our PDF with questions to ask your doctor about your prostate health during your next visit.

What Is the Cost of a 4Kscore Test and Will Insurance Cover It?

We often hear from patients and physicians interested in learning more about the cost associated with the 4Kscore test, and whether the test is covered under Medicare, Medicaid or other health insurance plans. This is a confusing area and the answers always vary – because of different insurance carriers and plans.

Bridging the Gap Between PSA and Biopsies

With nearly 3 million men currently living with prostate cancer in the United States, early detection of the disease is paramount.  Early detection of prostate cancer begins with screening the Prostate Specific Antigen (PSA) to assess the health of the prostate. If a PSA test result is high, often times a doctor may recommend a biopsy. However, because the PSA test cannot distinguish between aggressive prostate cancer and other less serious conditions, many men with a high PSA may be subjected to unnecessary prostate biopsies.

The 4Kscore is a simple blood test intended to help reduce the need for unnecessary biopsies. If the 4Kscore determines that a patient’s risk factor of having aggressive prostate cancer is low, the patient, in consultation with his physician, may decide not to have a prostate biopsy. The 4Kscore is helping many to avoid the cost of a biopsy, as well as reduce associated pain and complications, which can include: fever, bleeding, infection, and transient urinary difficulties.

The Cost of the 4Kscore Test

We are proud to offer 4Kscore tests at reasonable prices as part of our Patient Health Advocacy Program to increase access to comprehensive testing for patients who do not have health insurance or for those who choose not to submit a claim to their insurance company.  If you would like to discuss your specific situation and our self-pay and payment plan options, please call our specialized billing hotline at 855-4KBILLING (855-452-4554) between the hours of 9am and 9pm EST, Monday-Friday.

Is It Covered By My Insurance?

Because all insurance plans are different, coverage for laboratory testing depends on your particular insurance company and plan. We like to personally address specific needs to determine if the cost of the 4Kscore is covered under your insurance plan. Please call our specialized billing hotline at 855-4KBILLING (855-452-4554) between the hours of 9am and 9pm EST, Monday-Friday to discuss insurance coverage.

Once a patient has undergone the 4Kscore test, if an insurance company does not pay the filed claim because the insurance company deems the test investigational, not a covered service or an out-of network service, we will file an appeal on the patient’s behalf. The patient will only be responsible for applicable copayment, coinsurance and/or deductible amounts, unless prior written arrangements have been made with the patient.

The Cost of Unnecessary Biopsies

Beyond the cost of the 4Kscore test, it is also important to consider the cost of undergoing unnecessary biopsy. As a result of rising coinsurance, copayments, and deductibles, in many cases, insurance companies do not fully reimburse for the cost of a biopsy. In addition to the cost of the procedure itself, prostate biopsies require resources in the Urologist’s practice and at the pathology lab, costs which are passed onto patients and insurance companies alike. The 4Kscore has the ability to reduce unnecessary biopsies and overtreatment of indolent prostate cancer saving the US healthcare system billions of dollars – that is some serious savings!

Still Have A Billing Question?

Insurance cost and coverage can be tricky to navigate, but we are always here to help to ensure the 4Kscore test is an affordable option for men at risk of developing prostate cancer. If you have more questions about the 4Kscore test, email us at 4KscoreInquiry@BioReference.com.

~~~~~

If you are interested in learning more about prostate health, follow our blog and connect with us on Facebook, Twitter, Google+ and LinkedIn.

Happy New Year! How Your Resolution Can do More than Trim Your Waistline

Are you resolving to get into shape this New Year? If so, you are not alone. According to a 2015 Nielsen study, 37% of those surveyed listed staying fit and healthy as their New Year’s resolution while 32% were focused on weight loss. [1] As we move into 2017, it is safe to assume that these goals remain among the most common resolutions of the New Year. If you hope to improve your health in the coming months, we applaud you! After all, a healthier lifestyle not only makes you look and feel better, it can reduce your risk factor for a multitude of health problems.

Body Mass and Cancer Risk [2]

The World Cancer Research Fund estimates that roughly 20% of cancers diagnosed each year in the United States are linked to preventable health issues – including excess body fat, lack of physical exercise, excess consumption of alcohol, and/or poor nutrition.  While all of these variables may contribute to one’s cancer risk, excess body weight seems to have the strongest correlation, contributing to as many as 1 in 5 of all cancer-related deaths.

Carrying excess body weight is linked with an increased risk of many types of cancer including breast cancer, endometrium cancer, esophagus cancer, colon and rectum cancer, pancreas cancer, and kidney cancer. In addition, being overweight or obese may potentially raise one’s risk of developing aggressive forms of prostate cancer, gallbladder cancer, non-Hodgkin lymphoma, liver cancer, multiple myeloma cancer, cervix cancer, and ovarian cancer.

Health in the New Year

Studies tells us that carrying excess body fat is not only hard on the heart, it can contribute to your cancer risk factor, being all the more reason to set health goals in 2017 and resolve to stick to them. Carve out time each week to exercise to help you stay fit, and make a conscious effort to eat a diet rich in vitamins and nutrients.

Another factor that can contribute to cancer risk, including prostate cancer risk, is family health history. Don’t miss our recent post to learn more about genetic predispositions for developing cancer. If you or a loved one have reason to believe that you are at an increased risk of prostate cancer, we encourage you to remain vigilant.  By regularly visiting your doctor and undergoing blood tests, you can assess your risk of developing aggressive prostate cancer. The 4Kscore is an advanced blood test that predicts a man’s risk percent of having aggressive prostate cancer in a biopsy on a scale of <1% to >95%.

Setting Your Health Resolutions

As we kick off 2017, we encourage you to resolve to live a healthier lifestyle – not just by trimming your waistline, but also by talking with your family about your health history, visiting your doctor regularly, and reducing your disease risk. And if you’re a man with an elevated PSA, check your risk for aggressive prostate cancer with the 4Kscore test.

Would you like to receive more health tips and insight in the coming year? Subscribe to our blog!

  • This Year’s Top New Year’s Resolution? Fitness!! Available at https://www.nielsen.com/us/en/insights/news/2015/2015s-top-new-years-resolution-fitness.html. (Accessed December 11, 2016).
  • American Cancer Society. Does body weight affect cancer risk? Available at https://www.cancer.org/cancer/cancercauses/dietandphysicalactivity/bodyweightandcancerrisk/body-weight-and-cancer-risk-effects. (Accessed December 11, 2016)

Home for the Holidays: Family History and Prostate Cancer Risk

For many of us, the holidays are a time to travel home and spend with family and friends. During these joyous occasions, it’s important to reflect on the past and look forward to the future. As you sit down with relatives and share memories, this is also an opportunity to ask questions and have meaningful conversations about your health. Though family health history is a topic that doesn’t always come up, there is no better time to ask questions and learn about your genealogy than when you are gathered together. Knowing your family history can help you understand your risk of developing a wide range of health problems, such as heart disease and certain types of cancer, including cancer of the prostate.

Family Health History and Prostate Cancer

Many studies have demonstrated a genetic contribution to prostate cancer risk. Members of families with the following characteristics may especially want to consider genetic consultation:

  • Having multiple first-degree relatives with a prostate cancer diagnosis
  • Early-onset prostate cancer (age ≤55 years)
  • Those with a family history of prostate cancer along with other types of cancers (e.g., breast, ovarian, pancreatic). [1]

Know Your Family Health History

Research tells us that one’s genetic predisposition for developing cancer reaches beyond cancer of the prostate. In fact, inherited genetic mutations are believed to contribute to 5 to 10 percent of all cancers. [2] This is why it’s important to take the time to discuss family health history when your loved ones are together. Taking a proactive approach can lead to early detection of disease, which can saves lives. We encourage you to ask questions this holiday season – Learn about your family medical history and do your part to educate your relatives about instances of cancer and other disease in your lineage.

4Kscore Test: Simple Prostate Cancer Blood Test

If you or a loved have a family health history of prostate cancer, or other types of cancer, it is important to monitor your health. The 4Kscore checks four prostate-specific biomarkers and clinical information to predict a man’s risk of aggressive prostate cancer. This simple blood test is performed after an abnormal PSA, and can help you and your loved ones specifically determine the risk of aggressive prostate cancer prior to making a prostate biopsy decision. Do your part this holiday season to have the discussion and encourage those you hold dear to take an active role in monitoring their health.

Would you like to receive more insight on the health issues that impact you and your family? Subscribe to our blog.

  • National Cancer Institute. Genetics of Prostate Cancer (PDQ®)–Health Professional Version. Available https://www.cancer.gov/types/prostate/hp/prostate-genetics-pdq. (Accessed December 8, 2016).
  • National Cancer Institute. Genetic Testing for Hereditary Cancer Syndromes. Available https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet. (Accessed December 8, 2016).

This Season, Give the Gift of Information

With so much to consider this time of year, from holiday shopping to social engagements, it’s easy to lose focus of our health. What if you could give a thoughtful gift this year, that shifts focus to your health and that of your loved ones? Rather than getting caught up in the hustle and bustle of holiday commercialism, why not give the men you love peace of mind for their prostate health with information about the 4Kscore.

Peace of Mind for Prostate Health

Prostate cancer risk factors impact us all. Research tells us that 1 in every 7 men will develop some form of prostate cancer in their lifetime. Even if you are not at risk of prostate cancer, chances are someone you love is. This is why we encourage you to share information about the 4Kscore test this season. Whether you choose to have a conversation with your physician about prostate cancer yourself, or you encourage a loved one to do so, you will be giving a gift that doesn’t expire – knowledge about prostate cancer risk and test options.

How Does the 4Kscore Test Work?

If you, or a loved one, have been concerned with prostate health, chances are you are familiar with the PSA test. Unlike the 4Kscore, PSA tests do not clearly differentiate between aggressive prostate cancer and less serious health conditions. Because of this, men with high PSA results may be subjected to unnecessary medical procedures.

The 4Kscore is a follow up test after an abnormal PSA result, and is more specific for aggressive prostate cancer. The 4Kscore combines the values of four prostate-specific kallikreins in the blood (Total PSA, Free PSA, Intact PSA, and Human Kallikrein 2 (hK2)), with age, digital rectal exam results and prior biopsy history to arrive at a personal risk score for each patient. The resulting 4Kscore predicts a patient’s risk of high grade prostate cancer on a scale from <1% to >95%, and the long-term risk of developing metastatic prostate cancer. The 4Kscore has the potential to dramatically increase the accuracy of prostate cancer diagnosis, and provide men with peace of mind for their prostate health.

Give a Gift that Shows You Care About His Health

If a loved one has an abnormal PSA, the 4Kscore can provide them with peace of mind for their prostate health. This season, give your loved ones the gift of information about their prostate cancer risk and the 4Kscore test. Encourage them to contact their physician, ask the right questions, and get tested at a 4Kscore test laboratory.

Would you like more tips and information on prostate health? Subscribe to our blog for insights and information on the risk factors, diagnosis and prevention of prostate cancer.